FeedPosted Mar 3rd 2011 4:00PM by Joseph Lazzaro (RSS feed)
Filed under: CIGNA Corp (CI), Stocks to Buy

Normally slow-moving Cigna Corporation (
CI), first discussed here on May 28, 2009 at a price of $21.89, has been on the move, rising $7 from about $35 to $42, and I obviously still like the shares at this juncture.
Cigna's should post a 1-3% revenue gain in 2011, after a 17% increase in 2010. CI's health care unit should lead the way, with the unit's revenue advancing on both increased subscribers and higher premiums. What's more, the retention rates for new products for individual, small-group, and middle market customers have been impressive. Products for national accounts, however, less-impressive.
Continue reading Cigna Races Higher
Posted Feb 3rd 2011 8:30AM by Jason Raznick (RSS feed)
Filed under: Before the Bell, International Markets, Wal-Mart (WMT), Market Matters, New York Times'A' (NYT), CIGNA Corp (CI), Yum Brands (YUM), Merck and Co (MRK), Commodities, Oil, Currency, Royal Dutch Shell (RDS.A)

U.S. stock futures are mixed this morning, as investors await jobless-claims data and
earnings report from Merck (
MRK). Futures on the
Dow Jones Industrial Average rose 7 points to 11,992 and S&P 500 futures fell 0.40 point to 1,299.60. Nasdaq 100 futures fell 3.50 to 2,316.25.
The Dow index gained 1.81 points or 0.02% to close at 12,042 yesterday.
Data on weekly jobless claims and fourth quarter productivity will be released at 8:30 a.m. ET. The ISM report on service sector activity in January and factory orders for December will both be released at 10 a.m. ET.
US retailers such as Wal-Mart Stores (
WMT) are scheduled to report same-store sales for January.
Continue reading Futures Mixed Ahead of Earnings, Economic Data, Retail Sales
Posted Jan 6th 2011 11:40AM by Eric Buscemi (RSS feed)
Filed under: Analyst Reports, Analyst Upgrades and Downgrades, Exxon Mobil (XOM), Netflix, Inc. (NFLX), BB and T (BBT), CIGNA Corp (CI), Hershey Co (HSY), Toll Brothers (TOL), Analyst Initiations
Analyst Upgrades
- Exxon Mobil (XOM) and BB&T (BBT) to outperform from perform at Oppenheimer.
- D.R. Horton (DHI) upgraded to outperform from market perform at Wells Fargo.
- Meritage Homes (MTH), Old Dominion Freight (ODFL) and Heartland Payment (HPY) to outperform from market perform at Wells Fargo.
- Toll Brothers (TOL) to overweight from equal weight at Barclays.
- Hershey (HSY) to buy from neutral at Janney Capital.
- UnitedHealth (UNH), Cigna (CI) and Allscripts (MDRX) to buy from hold at Deutsche Bank.
- Nationwide Health (NHP) to outperform from market perform at JMP Securities.
- Reynolds American (RAI) to buy from neutral at UBS.
- Adtran (ADTN), PG&E (PCG) and Wisconsin Energy (WEC) to overweight from equal weight at Morgan Stanley.
Continue reading Analyst Calls: BBT, CI, DG, DHI, HSY, NFLX, RAI, TOL, UNH, WAT, XOM ...
Posted Dec 17th 2010 2:00PM by Joseph Lazzaro (RSS feed)
Filed under: CIGNA Corp (CI), Stocks to Buy

Insurer Cigna Corp. (
CI), first discussed here
on May 28, 2009 at a price of $21.89, has
moved out of a trough recorded this summer, and I obviously still like the shares at this juncture.
Cigna should post a 1-3% revenue gain in 2011, after a likely double-digit increase in 2010. CI's health care unit should lead the way, with the unit's revenue advancing on both increased subscribers and higher premiums. What's more, the retention rate for new products for individual, small-group, and middle market customers has been impressive; products for national accounts, less-impressive.
Continue reading Cigna: A Slow Mover That Rewards Patience
Posted Nov 12th 2010 11:30AM by Eric Buscemi (RSS feed)
Filed under: Analyst Reports, Analyst Upgrades and Downgrades, Altria Group (MO), Bed Bath and Beyond (BBBY), Boeing Co (BA), CIGNA Corp (CI), Analyst Initiations, Eaton Corp (ETN), MetLife Inc. (MET)
Analyst Upgrades
- Goldman upgraded Eaton (ETN) to conviction buy from neutral.
- AECOM Technology (ACM) was upgraded to outperform from neutral at Macquarie.
- Piper Jaffray upgraded Hologic (HOLX), Gen-Probe (GPRO) and Qiagen (QGEN) to overweight from neutral.
- GeoMet (GMET) was upgraded to accumulate from neutral at Global Hunter.
- Accretive Health (AH) was upgraded to outperform from neutral at RW Baird.
- Morgan Stanley upgraded Reinsurance Group (RGA) to overweight from equal weight.
- BofA/Merrill upgraded Clearwire (CLWR) to neutral from underperform.
Continue reading Analyst Calls: BA, BBBY, CI, CLWR, DFS, DLTR, ETN, MET, MO, WSM ...
Posted Sep 13th 2010 3:00PM by Joseph Lazzaro (RSS feed)
Filed under: CIGNA Corp (CI), Stocks to Buy
I first discussed Cigna Corp. (CI) here on May 28, 2009, at a price of $21.89, and shares of insurer have meandered this summer, but just look on that sideways action as a chance to scoop-up shares of a premiere insurer at a decent price.
Cigna's health care unit should lead the way this year, with revenue increasing 15% to 20% in 2010, on both increased subscribers and higher premiums. Further, Cigna's group disability and life insurance units should also notch improved performances in 2010.
Continue reading Is Cigna Poised to Move Higher?
Posted May 11th 2010 5:00PM by Joseph Lazzaro (RSS feed)
Filed under: Earnings Reports, CIGNA Corp (CI), Stocks to Buy

Insurer CIGNA Corporation (
CI) posted solid first quarter earnings of
$1.01 per share, excluding items, compared to the Thomson/Reuters First Call estimate of
90 cents. So far, investors are more than satisfied. Cigna's shares rose about 75 cents after the earnings release, and recently have recovered nearly all of the ground lost during the May 6 "flash crash." On Tuesday afternoon shares rose 87 cents to $33.52. Cigna earned 76 cents per share a year ago.
Cigna, which benefited from a strong international performance, also kept its 2010 earnings guidance the same, with the company seeing full-year EPS of
$3.75 to $4.15, compared to the First Call estimate of
$4.08. First Call also expects CI to earn
$4.36 in 2011.
Continue reading Cigna's Q1 Beats Street on Global Performance
Posted May 6th 2010 8:23AM by Melly Alazraki (RSS feed)
Filed under: Before the Bell, International Markets, Market Matters, CIGNA Corp (CI), Costco Wholesale (COST), BP p.l.c. ADS (BP), Alcatel-LucentADS (ALU), Economic Data

U.S. stock futures, which inched higher earlier Thursday morning, now turned lower even after several selloff sessions the past week due to concerns over the debt crisis in Greece and contagion probability across Europe. While Wall Street awaits some data on employment and retail among others, the European Central Bank has decided on interest rates.
Once again, U.S. stocks finished the session lower Wednesday, albeit with smaller declines. Civil unrest in Greece,
fear of contagion and the euro sliding to 14-month lows were signs the crisis in Europe was deepening.
Continue reading Before the Bell: Futures Lower on European Debt Crisis Concerns
Posted Apr 26th 2010 5:00PM by Steven Mallas (RSS feed)
Filed under: Earnings Reports, Aetna Inc (AET), CIGNA Corp (CI)
Humana Inc. (HUM), whose colleagues include Aetna Inc. (AET) and CIGNA Corporation (CI), reported Q1 earnings earlier today. The health insurer isn't doing so well, unfortunately. In late trading, shares were down almost 3% to $43.73. Volume is above the norm, as you might expect.
I've covered many stocks that are near their 52-week highs, but this one doesn't fall into such a desirable category. Alas, the 52-week high on the shares stands at $52.66. And, as you can see from the following one-year chart, the stock began its pullback after it topped out in January. Since then, things haven't been too exciting.
Continue reading Humana Dips on Q1 Report
Posted Feb 3rd 2010 9:00AM by Paul Foster (RSS feed)
Filed under: CIGNA Corp (CI), Monster Worldwide (MNST), Options
Cigna (CI) closed at $35.24. CI is expected to report Q4 EPS on February 4. February option implied volatility is at 45, March is at 43, April is at 42, versus its 26-week average of 43, according to Track Data, suggesting non-directional price movement,
Monster Worldwide (MWW) closed at $16.04. MWW is expected to report Q4 EPS on February 3. February put option implied volatility is at 54, March and June puts are at 49, versus its 26-week average of 53 according to Track Data suggesting non-directional price movement.
Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com
Posted Nov 23rd 2009 4:00PM by Jon Ogg (RSS feed)
Filed under: eBay (EBAY), Starbucks (SBUX), CIGNA Corp (CI)

Today started out strong and stayed positive all day, even if some commented that the highs were not held. The weak dollar helped commodities and helped stocks. A 10.1% October sales rise by the National Association of Realtors by those trying to get the home buyer tax credit didn't hurt either. Ditto for a reiteration that the
recession is over.
Here were today's unofficial closing bell levels:
Dow 10,450.04 +131.88 (1.28%)
S&P 500 1,106.13 +14.75 (1.35%)
Nasdaq 2,175.96 +29.92 (1.39%)
Top Day Trader AlertsTop 10 Analyst CallsTop Stock/Market RumorsContinue reading Closing Bell: Stock bulls and dollar death (DDRX,GMCR, PEET, SBUX, EBAY, CI, TECD)
Posted Nov 9th 2009 10:10AM by Jim Cramer (RSS feed)
Filed under: Market Matters, Abbott Laboratories (ABT), Aetna Inc (AET), CIGNA Corp (CI), Gilead Sciences (GILD), Stocks to Buy, Cramer on BloggingStocks
TheStreet.com's Jim Cramer says the Senate is filled with more-savvy politicians, and the upside for beaten-down names is huge. Nancy Pelosi has now said her piece. The most unpopular Speaker of the House in the history of Wall Street has gotten her precious health care legislation through the House after ramming through a stimulus package that had far too little infrastructure and far too much pay raise for municipal and state workers, the most powerful interest group in the country.
But this time the Senate sees through it, and the politicians -- despite Pelosi's insistence that Tuesday's election went her way -- know better. There are pages after pages after pages in this bill that look threatening. But here's the rub: This bill's public option, the one that is supposed to be a killer to everything health care, should affect no more than 6 million people over a 10-year period, according to the Congressional Budget Office. In order to get 60 votes in the Senate, even that may prove to be too powerful an option.
Continue reading Cramer on BloggingStocks: Pelosi can't kill the health care sector
Posted Sep 21st 2009 5:20PM by Joseph Lazzaro (RSS feed)
Filed under: CIGNA Corp (CI), Stocks to Buy

A late-May conclusion arguing that institutional investors had started to re-commit to Cigna Corp., due to its
constructive, staircase chart, virtually no breaches of the 50-day moving average, and adequate earnings outlook, has so far proved to be on-the-mark.
Hence, I'm reiterating my Buy rating for
Cigna Corp. (NYSE:
CI), first recommended
on May 28, 2009 at a price of $21.89. If you bought CI then, you're up about 45%.
Continue reading Cigna: A positive signal-filled chart
Next Page »